Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Hug

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cell|November 13, 2004
HDAC4: a corepressor controlling bone developmentBruce A Hug
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2004
Fusion-protein truncation provides new insights into leukemogenesisJay L Hess, Bruce A Hug
Oncogene|May 25, 2004
ETO interacting proteinsBruce A Hug, Mitchell A Lazar
International Journal of Cancer|November 9, 2011
A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjectsRichat Abbas, Bruce A Hug, Cathie Leister, et al.
Cancer Chemotherapy and Pharmacology|March 16, 2012
A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitorRichat Abbas, Bruce A Hug, Cathie Leister, et al.
British Journal of Clinical Pharmacology|March 15, 2011
Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjectsRichat Abbas, Bruce A Hug, Cathie Leister, et al.
The Journal of Biological Chemistry|October 17, 2003
A chromatin immunoprecipitation screen reveals protein kinase Cbeta as a direct RUNX1 target geneBruce A Hug, Nazia Ahmed, Jonathan A Robbins, et al.
Journal of Clinical Pharmacology|December 15, 2010
Effect of ketoconazole on the pharmacokinetics of oral bosutinib in healthy subjectsRichat Abbas, Bruce A Hug, Cathie Leister, et al.
Pigment Cell & Melanoma Research|May 22, 2015
Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumabDavid R Minor, Igor Puzanov, Margaret K Callahan, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2011
A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjectsRichat Abbas, Bruce A Hug, Cathie Leister, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cell|November 13, 2004
HDAC4: a corepressor controlling bone developmentBruce A Hug
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2004
Fusion-protein truncation provides new insights into leukemogenesisJay L Hess, Bruce A Hug
Oncogene|May 25, 2004
ETO interacting proteinsBruce A Hug, Mitchell A Lazar
International Journal of Cancer|November 9, 2011
A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjectsRichat Abbas, Bruce A Hug, Cathie Leister, et al.
Cancer Chemotherapy and Pharmacology|March 16, 2012
A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitorRichat Abbas, Bruce A Hug, Cathie Leister, et al.
British Journal of Clinical Pharmacology|March 15, 2011
Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjectsRichat Abbas, Bruce A Hug, Cathie Leister, et al.
The Journal of Biological Chemistry|October 17, 2003
A chromatin immunoprecipitation screen reveals protein kinase Cbeta as a direct RUNX1 target geneBruce A Hug, Nazia Ahmed, Jonathan A Robbins, et al.
Journal of Clinical Pharmacology|December 15, 2010
Effect of ketoconazole on the pharmacokinetics of oral bosutinib in healthy subjectsRichat Abbas, Bruce A Hug, Cathie Leister, et al.
Pigment Cell & Melanoma Research|May 22, 2015
Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumabDavid R Minor, Igor Puzanov, Margaret K Callahan, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2011
A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjectsRichat Abbas, Bruce A Hug, Cathie Leister, et al.
Pageof 2